Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-9193

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model ; volume:10 ; number:1 ; day:29 ; month:1 ; year:2018 ; pages:1-16 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (29.1.2018), 1-16, 12.2018

Creator: Goñi, Fernando

Contributor: Martá-Ariza, Mitchell
Herline, Krystal
Peyser, Daniel
Boutajangout, Allal
Mehta, Pankaj
Drummond, Eleanor
Prelli, Frances
Wisniewski, Thomas
SpringerLink (Online service)

DOI: 10.1186/s13195-018-0337-3

URN: urn:nbn:de:101:1-2018090610273063357081

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Goñi, Fernando
Martá-Ariza, Mitchell
Herline, Krystal
Peyser, Daniel
Boutajangout, Allal
Mehta, Pankaj
Drummond, Eleanor
Prelli, Frances
Wisniewski, Thomas
SpringerLink (Online service)

Other Objects (12)

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Hidden variations of Alzheimer’s pathology : Insight into the amyloid diversity using conformation-sensitive dyes

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

TDP-43 Pathology in Alzheimer’s Disease

Microglial immunophenotype in dementia with Alzheimer’s pathology

Role of liraglutide in Alzheimer’s disease pathology

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease

The intellectual disability gene PQBP1 rescues Alzheimer’s disease pathology

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Hidden variations of Alzheimer’s pathology : Insight into the amyloid diversity using conformation-sensitive dyes

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

TDP-43 Pathology in Alzheimer’s Disease

Microglial immunophenotype in dementia with Alzheimer’s pathology

Role of liraglutide in Alzheimer’s disease pathology

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease

The intellectual disability gene PQBP1 rescues Alzheimer’s disease pathology

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Hidden variations of Alzheimer’s pathology : Insight into the amyloid diversity using conformation-sensitive dyes

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

TDP-43 Pathology in Alzheimer’s Disease

Microglial immunophenotype in dementia with Alzheimer’s pathology

Role of liraglutide in Alzheimer’s disease pathology

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease

The intellectual disability gene PQBP1 rescues Alzheimer’s disease pathology

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Hidden variations of Alzheimer’s pathology : Insight into the amyloid diversity using conformation-sensitive dyes

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

TDP-43 Pathology in Alzheimer’s Disease

Microglial immunophenotype in dementia with Alzheimer’s pathology

Role of liraglutide in Alzheimer’s disease pathology

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease

The intellectual disability gene PQBP1 rescues Alzheimer’s disease pathology

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Hidden variations of Alzheimer’s pathology : Insight into the amyloid diversity using conformation-sensitive dyes

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

TDP-43 Pathology in Alzheimer’s Disease

Microglial immunophenotype in dementia with Alzheimer’s pathology

Role of liraglutide in Alzheimer’s disease pathology

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease

The intellectual disability gene PQBP1 rescues Alzheimer’s disease pathology

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology

Hidden variations of Alzheimer’s pathology : Insight into the amyloid diversity using conformation-sensitive dyes

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

TDP-43 Pathology in Alzheimer’s Disease

Microglial immunophenotype in dementia with Alzheimer’s pathology

Role of liraglutide in Alzheimer’s disease pathology

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease

The intellectual disability gene PQBP1 rescues Alzheimer’s disease pathology

Related objects

Reset password